Arno Therapeutics (OTCMKTS:ARNI) Stock Price Crosses Above 50-Day Moving Average – Should You Sell?

Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.

Arno Therapeutics Stock Down 100.0%

Get Arno Therapeutics alerts:

About Arno Therapeutics

(Get Free Report)

Arno Therapeutics, Inc (OTCMKTS:ARNI) is a development‐stage biopharmaceutical company focused on the research and development of targeted therapeutics for oncology indications and rare genetic disorders. The company’s mission is to apply innovative biologic and protein engineering platforms to create therapies that address significant unmet medical needs in cancer and inherited metabolic conditions.

Arno’s pipeline centers on antibody‐based drug conjugates and recombinant fusion proteins designed to selectively target tumor cells or restore deficient enzyme activity in rare diseases.

See Also

• Five stocks we like better than Arno Therapeutics
• Datadog’s Drop Says More About Expectations Than Earnings
• D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
• Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
• Solventum Nears Inflection Point As It Begins to Unlock Value

Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.